Ethris and Partners Receive Horizon 2020 Grant to Explore New Therapeutic Paradigm in Cardiac Regeneration Ethris2020-02-11T08:58:41+01:00October 30th, 2019| Read More
Ethris and Partners Receive Eurostars Grant for the Development of New mRNA Therapeutics for Osteoarthritis Ethris2019-10-10T12:37:47+01:00July 24th, 2019| Read More
Ethris’ Collaborators at LMU München Children’s Hospital Publish Paper in Nature Nanotechnology Ethris2019-10-10T12:35:43+01:00January 28th, 2019| Read More
Efficient ex vivo delivery of chemically modified messenger RNA using lipofection and magnetofection. Ethris2017-02-13T12:06:51+01:00February 13th, 2017| Read More
Modified mRNA for BMP-2 in Combination with Biomaterials Serves as a Transcript-Activated Matrix for Effectively Inducing Osteogenic Pathways in Stem Cells Ethris2017-02-09T13:16:48+01:00February 9th, 2017| Read More
Transcript-activated collagen matrix as sustained mRNA delivery system for bone regeneration Ethris2017-02-13T11:36:40+01:00January 1st, 2017| Read More
Stability analysis of chemically modified mRNA using micropattern-based single-cell arrays Ethris2017-01-01T20:34:16+01:00January 1st, 2017| Read More
Human cellular CYBA UTR sequences increase mRNA translation without affecting the half-life of recombinant RNA transcripts. Ethris2017-01-01T20:34:06+01:00January 1st, 2017| Read More
Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats Ethris2017-02-13T11:54:37+01:00January 1st, 2017| Read More
Single Methylene Group in Oligoalkylamine‐Based Cationic Polymers and Lipids Promotes Enhanced mRNA Delivery Ethris2017-01-01T20:33:44+01:00January 1st, 2017| Read More
Preclinical study with SNIM® RNA published in Nature Biotechnology Ethris2017-02-09T13:02:36+01:00January 1st, 2017| Read More
